FDA Week - 08/23/2019

HHS To Appeal Court Decision Striking Down DTC Ad Rule

By Rachel Cohrs / August 21, 2019 at 2:21 PM
Updated Story HHS will appeal a court decision that struck down a Trump administration rule requiring drug makers to disclose list prices in television advertisements, the department said in a court filing on Wednesday (Aug. 21) . The U.S. District Court for the District of Columbia on July 8 ruled that HHS did not have the authority to force drug makers to include list prices in ads. The rule was one of HHS’ marquee drug-pricing policies before...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.